These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16672391)

  • 1. Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.
    Persson KE; Lee CT; Marsh K; Beeson JG
    J Clin Microbiol; 2006 May; 44(5):1665-73. PubMed ID: 16672391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays.
    Wilson DW; Crabb BS; Beeson JG
    Malar J; 2010 Jun; 9():152. PubMed ID: 20525251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J
    Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria.
    Boyle MJ; Reiling L; Feng G; Langer C; Osier FH; Aspeling-Jones H; Cheng YS; Stubbs J; Tetteh KK; Conway DJ; McCarthy JS; Muller I; Marsh K; Anders RF; Beeson JG
    Immunity; 2015 Mar; 42(3):580-90. PubMed ID: 25786180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum infection and age influence parasite growth inhibition mediated by IgG in Beninese infants.
    Adamou R; Chénou F; Sadissou I; Sonon P; Dechavanne C; Djilali-Saïah A; Cottrell G; Le Port A; Massougbodji A; Remarque EJ; Luty AJ; Sanni A; Garcia A; Migot-Nabias F; Milet J; Courtin D
    Acta Trop; 2016 Jul; 159():111-9. PubMed ID: 27001144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.
    Dent AE; Bergmann-Leitner ES; Wilson DW; Tisch DJ; Kimmel R; Vulule J; Sumba PO; Beeson JG; Angov E; Moormann AM; Kazura JW
    PLoS One; 2008; 3(10):e3557. PubMed ID: 18958285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of inhibitory epitopes in the Plasmodium falciparum rhoptry protein RAP-1 including identification of a second inhibitory epitope.
    Howard RF; Jacobson KC; Rickel E; Thurman J
    Infect Immun; 1998 Jan; 66(1):380-6. PubMed ID: 9423886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.
    McCallum FJ; Persson KE; Mugyenyi CK; Fowkes FJ; Simpson JA; Richards JS; Williams TN; Marsh K; Beeson JG
    PLoS One; 2008; 3(10):e3571. PubMed ID: 18958278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miniaturization of a high-throughput pLDH-based Plasmodium falciparum growth inhibition assay for small volume samples from preclinical and clinical vaccine trials.
    Bergmann-Leitner ES; Duncan EH; Burge JR; Spring M; Angov E
    Am J Trop Med Hyg; 2008 Mar; 78(3):468-71. PubMed ID: 18337345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miniaturized Growth Inhibition Assay to Assess the Anti-blood Stage Activity of Antibodies.
    Duncan EH; Bergmann-Leitner ES
    Methods Mol Biol; 2015; 1325():153-65. PubMed ID: 26450387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
    Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
    Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites.
    Shi YP; Udhayakumar V; Oloo AJ; Nahlen BL; Lal AA
    Am J Trop Med Hyg; 1999 Jan; 60(1):135-41. PubMed ID: 9988337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated in vitro growth inhibition of field isolates of Plasmodium falciparum from asymptomatic children in Burkina Faso.
    Bolad A; Nebié I; Cuzin-Ouattara N; Traore A; Esposito F; Berzins K
    Am J Trop Med Hyg; 2003 Jun; 68(6):728-33. PubMed ID: 12887035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
    Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
    Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.